Hagens Berman Notifies Osiris Therapeutics, Inc. Investors of Class Action Settlement and January 30, 2019 Claims Deadline

National investor-rights law firm Hagens Berman Sobol Shapiro LLP reached a settlement on behalf of investors in Osiris Therapeutics, Inc. (NASDAQ: OSIR) (Osiris or the Company) who purchased shares between May 12, 2014 and November 16, 2015. The class action alleged violations of the federal securities laws. Named as defendants were Osiris, Lode Debrabandere, Gregory Law and Philip R. Jacoby, Jr. Settlement is pending final approval.

Class Members have until January 30, 2019 to submit a Proof of Claim and Release to receive a payment from the class action settlement.

If you purchased or otherwise acquired Osiris shares between May 12, 2014, and November 16, 2015, you may submit a claim for the settlement by downloading the claim form.

You may mail your completed and signed Proof of Claim and Release, postmarked no later than January 30, 2019, to the Settlement Administrator at:


Subscribe to the Global Banking & Finance Review Newsletter for FREE
Get Access to Exclusive Reports to Save Time & Money

By using this form you agree with the storage and handling of your data by this website. We Will Not Spam, Rent, or Sell Your Information.
All emails include an unsubscribe link. You may opt-out at any time. See our privacy policy.

Osiris Securities Settlement Settlement Administrator P.O. Box 4129 Portland, OR 97208-4129 [email protected]

About Hagens Berman

Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with 80+ attorneys in 10 offices across the country. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes can be found at www.hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

Reed Kathrein, 510-725-3000